• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023

    3/3/23 10:00:36 AM ET
    $AIMC
    $ARDX
    $ASAN
    $BILI
    Industrial Machinery/Components
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIMC alert in real time by email

    Upgrades

    JP Morgan upgraded the previous rating for Casey's General Stores Inc (NASDAQ:CASY) from Underweight to Neutral. In the second quarter, Casey's General Stores showed an EPS of $3.67, compared to $2.59 from the year-ago quarter. The stock has a 52-week-high of $249.90 and a 52-week-low of $170.82. At the end of the last trading period, Casey's General Stores closed at $211.24.

    Craig-Hallum upgraded the previous rating for LivePerson Inc (NASDAQ:LPSN) from Hold to Buy. For the third quarter, LivePerson had an EPS of $0.09, compared to year-ago quarter EPS of $0.47. The current stock performance of LivePerson shows a 52-week-high of $26.66 and a 52-week-low of $7.96. Moreover, at the end of the last trading period, the closing price was at $9.63.

    Goldman Sachs upgraded the previous rating for Samsara Inc (NYSE:IOT) from Neutral to Buy. Samsara earned $0.02 in the fourth quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Samsara shows a 52-week-high of $19.45 and a 52-week-low of $8.42. Moreover, at the end of the last trading period, the closing price was at $16.88.

    Evercore ISI Group upgraded the previous rating for Neurocrine Biosciences Inc (NASDAQ:NBIX) from In-Line to Outperform. For the fourth quarter, Neurocrine Biosciences had an EPS of $1.24, compared to year-ago quarter EPS of $0.04. The current stock performance of Neurocrine Biosciences shows a 52-week-high of $129.29 and a 52-week-low of $75.25. Moreover, at the end of the last trading period, the closing price was at $100.16.

    For Bilibili Inc (NASDAQ:BILI), Citigroup upgraded the previous rating of Neutral to Buy. Bilibili earned $0.48 in the fourth quarter, compared to $0.66 in the year-ago quarter. At the moment, the stock has a 52-week-high of $35.00 and a 52-week-low of $8.23. Bilibili closed at $21.57 at the end of the last trading period.

    According to UBS, the prior rating for First Solar Inc (NASDAQ:FSLR) was changed from Neutral to Buy. First Solar earned $0.07 in the fourth quarter, compared to $1.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $199.35 and a 52-week-low of $59.60. First Solar closed at $198.22 at the end of the last trading period.

    For Ardelyx Inc (NASDAQ:ARDX), Wedbush upgraded the previous rating of Neutral to Outperform. In the fourth quarter, Ardelyx showed an EPS of $0.06, compared to $0.31 from the year-ago quarter. The stock has a 52-week-high of $3.43 and a 52-week-low of $0.49. At the end of the last trading period, Ardelyx closed at $2.89.

    DA Davidson upgraded the previous rating for Asana Inc (NYSE:ASAN) from Neutral to Buy. In the third quarter, Asana showed an EPS of $0.26, compared to $0.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $55.10 and a 52-week-low of $11.32. Asana closed at $15.32 at the end of the last trading period.

    According to BMO Capital, the prior rating for Empire State Realty Trust Inc (NYSE:ESRT) was changed from Market Perform to Outperform. For the fourth quarter, Empire State Realty Trust had an EPS of $0.22, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of $10.05 and a 52-week-low of $6.24. Empire State Realty Trust closed at $7.63 at the end of the last trading period.

    Scotiabank upgraded the previous rating for The Toronto-Dominion Bank (NYSE:TD) from Sector Perform to Sector Outperform. Toronto-Dominion Bank earned $1.65 in the first quarter, compared to $1.64 in the year-ago quarter. The stock has a 52-week-high of $82.64 and a 52-week-low of $57.27. At the end of the last trading period, Toronto-Dominion Bank closed at $65.07.

    For The Kroger Co (NYSE:KR), JP Morgan upgraded the previous rating of Neutral to Overweight. In the fourth quarter, Kroger showed an EPS of $0.99, compared to $0.91 from the year-ago quarter. The current stock performance of Kroger shows a 52-week-high of $62.78 and a 52-week-low of $41.81. Moreover, at the end of the last trading period, the closing price was at $45.73.

    For RadNet Inc (NASDAQ:RDNT), Raymond James upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, RadNet showed an EPS of $0.11, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $24.41 and a 52-week-low of $12.03. RadNet closed at $23.81 at the end of the last trading period.

    According to Deutsche Bank, the prior rating for Flowers Foods Inc (NYSE:FLO) was changed from Sell to Hold. In the fourth quarter, Flowers Foods showed an EPS of $0.23, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $30.16 and a 52-week-low of $24.15. At the end of the last trading period, Flowers Foods closed at $27.75.

    For Marathon Petroleum Corp (NYSE:MPC), Jefferies upgraded the previous rating of Hold to Buy. Marathon Petroleum earned $6.65 in the fourth quarter, compared to $1.30 in the year-ago quarter. The current stock performance of Marathon Petroleum shows a 52-week-high of $136.46 and a 52-week-low of $73.17. Moreover, at the end of the last trading period, the closing price was at $129.63.

    JP Morgan upgraded the previous rating for Procter & Gamble Co (NYSE:PG) from Neutral to Overweight. Procter & Gamble earned $1.59 in the second quarter, compared to $1.66 in the year-ago quarter. The current stock performance of Procter & Gamble shows a 52-week-high of $164.90 and a 52-week-low of $122.18. Moreover, at the end of the last trading period, the closing price was at $139.93.

    According to Wells Fargo, the prior rating for Pioneer Natural Resources Co (NYSE:PXD) was changed from Underweight to Equal-Weight. In the fourth quarter, Pioneer Natural Resources showed an EPS of $5.91, compared to $4.58 from the year-ago quarter. At the moment, the stock has a 52-week-high of $288.46 and a 52-week-low of $190.99. Pioneer Natural Resources closed at $209.80 at the end of the last trading period.

    See all analyst ratings upgrades.

    Downgrades

    According to Craig-Hallum, the prior rating for CareDx Inc (NASDAQ:CDNA) was changed from Buy to Hold. CareDx earned $0.07 in the fourth quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $41.50 and a 52-week-low of $9.05. At the end of the last trading period, CareDx closed at $10.77.

    According to RBC Capital, the prior rating for StepStone Group Inc (NASDAQ:STEP) was changed from Outperform to Sector Perform. For the third quarter, StepStone Group had an EPS of $0.27, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $35.16 and a 52-week-low of $22.39. At the end of the last trading period, StepStone Group closed at $28.92.

    Raymond James downgraded the previous rating for CareDx Inc (NASDAQ:CDNA) from Strong Buy to Market Perform. CareDx earned $0.07 in the fourth quarter, compared to $0.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $41.50 and a 52-week-low of $9.05. CareDx closed at $10.77 at the end of the last trading period.

    For Vornado Realty Trust (NYSE:VNO), BMO Capital downgraded the previous rating of Market Perform to Underperform. For the fourth quarter, Vornado Realty had an EPS of $0.72, compared to year-ago quarter EPS of $0.81. The stock has a 52-week-high of $47.26 and a 52-week-low of $19.15. At the end of the last trading period, Vornado Realty closed at $19.60.

    BMO Capital downgraded the previous rating for Douglas Emmett Inc (NYSE:DEI) from Market Perform to Underperform. For the fourth quarter, Douglas Emmett had an EPS of $0.51, compared to year-ago quarter EPS of $0.48. The current stock performance of Douglas Emmett shows a 52-week-high of $34.70 and a 52-week-low of $13.77. Moreover, at the end of the last trading period, the closing price was at $14.28.

    For Domino's Pizza Inc (NYSE:DPZ), Gordon Haskett downgraded the previous rating of Buy to Hold. Domino's Pizza earned $4.43 in the fourth quarter, compared to $4.25 in the year-ago quarter. The stock has a 52-week-high of $430.94 and a 52-week-low of $291.00. At the end of the last trading period, Domino's Pizza closed at $305.32.

    For Radius Global Infrastructure Inc (NASDAQ:RADI), Credit Suisse downgraded the previous rating of Outperform to Neutral. For the third quarter, Radius Global Infr had an EPS of $0.23, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $16.52 and a 52-week-low of $7.97. Radius Global Infr closed at $14.59 at the end of the last trading period.

    According to JP Morgan, the prior rating for Itron Inc (NASDAQ:ITRI) was changed from Neutral to Underweight. Itron earned $0.71 in the fourth quarter, compared to $0.75 in the year-ago quarter. The stock has a 52-week-high of $60.61 and a 52-week-low of $39.38. At the end of the last trading period, Itron closed at $56.78.

    According to JP Morgan, the prior rating for Hormel Foods Corp (NYSE:HRL) was changed from Neutral to Underweight. For the first quarter, Hormel Foods had an EPS of $0.40, compared to year-ago quarter EPS of $0.44. At the moment, the stock has a 52-week-high of $55.11 and a 52-week-low of $40.72. Hormel Foods closed at $41.83 at the end of the last trading period.

    UBS downgraded the previous rating for DLocal Ltd (NASDAQ:DLO) from Buy to Sell. In the third quarter, DLocal showed an EPS of $0.10, compared to $0.06 from the year-ago quarter. The stock has a 52-week-high of $35.96 and a 52-week-low of $9.03. At the end of the last trading period, DLocal closed at $15.50.

    William Blair downgraded the previous rating for BRP Group Inc (NASDAQ:BRP) from Outperform to Market Perform. In the fourth quarter, BRP Group showed an EPS of $0.12, compared to $0.10 from the year-ago quarter. The current stock performance of BRP Group shows a 52-week-high of $33.34 and a 52-week-low of $17.08. Moreover, at the end of the last trading period, the closing price was at $27.86.

    Raymond James downgraded the previous rating for Radius Global Infrastructure Inc (NASDAQ:RADI) from Strong Buy to Underperform. Radius Global Infr earned $0.23 in the third quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.52 and a 52-week-low of $7.97. Radius Global Infr closed at $14.59 at the end of the last trading period.

    For Altra Industrial Motion Corp (NASDAQ:AIMC), Loop Capital downgraded the previous rating of Buy to Hold. For the fourth quarter, Altra Industrial Motion had an EPS of $0.73, compared to year-ago quarter EPS of $0.67. The current stock performance of Altra Industrial Motion shows a 52-week-high of $61.73 and a 52-week-low of $32.18. Moreover, at the end of the last trading period, the closing price was at $61.70.

    For Tesla Inc (NASDAQ:TSLA), KGI Securities downgraded the previous rating of Outperform to Neutral. For the fourth quarter, Tesla had an EPS of $1.19, compared to year-ago quarter EPS of $0.85. The current stock performance of Tesla shows a 52-week-high of $384.29 and a 52-week-low of $101.81. Moreover, at the end of the last trading period, the closing price was at $190.90.

    For Chesapeake Energy Corp (NASDAQ:CHK), Wells Fargo downgraded the previous rating of Overweight to Equal-Weight. Chesapeake Energy earned $4.22 in the fourth quarter, compared to $2.39 in the year-ago quarter. The stock has a 52-week-high of $107.31 and a 52-week-low of $72.50. At the end of the last trading period, Chesapeake Energy closed at $82.08.

    See all analyst ratings downgrades.

    Initiations

    For Enliven Therapeutics Inc (NASDAQ:ELVN), TD Cowen initiated coverage, by setting the current rating at Outperform. At the moment, the stock has a 52-week-high of $25.34 and a 52-week-low of $19.24. Enliven Therapeutics closed at $23.45 at the end of the last trading period.

    Dawson James initiated coverage on Geovax Labs Inc (NASDAQ:GOVX) with a Buy rating. The price target for Geovax Labs is set to $4.00. For the third quarter, Geovax Labs had an EPS of $0.17, compared to year-ago quarter EPS of $0.31. The stock has a 52-week-high of $4.30 and a 52-week-low of $0.53. At the end of the last trading period, Geovax Labs closed at $0.72.

    For The Trade Desk Inc (NASDAQ:TTD), BTIG initiated coverage, by setting the current rating at Neutral. Trade Desk earned $0.38 in the fourth quarter, compared to $0.42 in the year-ago quarter. The current stock performance of Trade Desk shows a 52-week-high of $83.46 and a 52-week-low of $39.00. Moreover, at the end of the last trading period, the closing price was at $56.39.

    Compass Point initiated coverage on CompoSecure Inc (NASDAQ:CMPO) with a Buy rating. The price target for CompoSecure is set to $15.00. In the fourth quarter, CompoSecure showed an EPS of $0.20, compared to $1.34 from the year-ago quarter. The stock has a 52-week-high of $8.13 and a 52-week-low of $4.26. At the end of the last trading period, CompoSecure closed at $6.43.

    Jefferies initiated coverage on Nogin Inc (NASDAQ:NOGN) with a Hold rating. The price target for Nogin is set to $0.50. The current stock performance of Nogin shows a 52-week-high of $9.99 and a 52-week-low of $0.41. Moreover, at the end of the last trading period, the closing price was at $0.50.

    See all analyst ratings initiations.

    Get the next $AIMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIMC
    $ARDX
    $ASAN
    $BILI

    CompanyDatePrice TargetRatingAnalyst
    Samsara Inc.
    $IOT
    2/11/2026$36.00Buy
    Goldman
    Marathon Petroleum Corporation
    $MPC
    2/4/2026$183.00 → $198.00Buy
    TD Cowen
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    First Solar Inc.
    $FSLR
    1/29/2026$263.00Outperform → Market Perform
    BMO Capital Markets
    Procter & Gamble Company
    $PG
    1/27/2026$156.00Buy → Hold
    TD Cowen
    The Trade Desk Inc.
    $TTD
    1/23/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    Procter & Gamble Company
    $PG
    1/23/2026$165.00Neutral → Overweight
    Analyst
    Casey's General Stores Inc.
    $CASY
    1/21/2026Buy → Neutral
    Northcoast
    More analyst ratings

    $AIMC
    $ARDX
    $ASAN
    $BILI
    SEC Filings

    View All

    SEC Form 10-K filed by Neurocrine Biosciences Inc.

    10-K - NEUROCRINE BIOSCIENCES INC (0000914475) (Filer)

    2/11/26 4:03:36 PM ET
    $NBIX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Neurocrine Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - NEUROCRINE BIOSCIENCES INC (0000914475) (Filer)

    2/11/26 4:02:00 PM ET
    $NBIX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Douglas Emmett Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Douglas Emmett Inc (0001364250) (Filer)

    2/10/26 4:10:23 PM ET
    $DEI
    Real Estate Investment Trusts
    Real Estate

    $AIMC
    $ARDX
    $ASAN
    $BILI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF SCIENTIFIC OFFICER Lyssikatos Joseph P sold $145,219 worth of shares (5,000 units at $29.04) (SEC Form 4)

    4 - Enliven Therapeutics, Inc. (0001672619) (Issuer)

    2/10/26 6:12:02 PM ET
    $ELVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by EVP- HEAD OF RETAIL Chera Haim

    4 - VORNADO REALTY TRUST (0000899689) (Issuer)

    2/6/26 4:30:20 PM ET
    $VNO
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by CHAIRMAN AND CEO Roth Steven

    4 - VORNADO REALTY TRUST (0000899689) (Issuer)

    2/6/26 4:30:05 PM ET
    $VNO
    Real Estate Investment Trusts
    Real Estate

    $AIMC
    $ARDX
    $ASAN
    $BILI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Castanon Moats Maria bought $166,398 worth of shares (300 units at $554.66), increasing direct ownership by 60% to 803 units (SEC Form 4)

    4 - CASEYS GENERAL STORES INC (0000726958) (Issuer)

    1/6/26 2:20:38 PM ET
    $CASY
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Director Stith Melvin T bought $4,972 worth of shares (456 units at $10.90) (SEC Form 4)

    4 - FLOWERS FOODS INC (0001128928) (Issuer)

    12/5/25 2:17:42 PM ET
    $FLO
    Packaged Foods
    Consumer Staples

    EVP, GEN COUNSEL & SECRETARY Aronson Michele L bought $492,557 worth of shares (42,126 units at $11.69) (SEC Form 4)

    4 - Douglas Emmett Inc (0001364250) (Issuer)

    11/18/25 4:02:04 PM ET
    $DEI
    Real Estate Investment Trusts
    Real Estate

    $AIMC
    $ARDX
    $ASAN
    $BILI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 13, 2024 - FDA Approves New Treatment for Congenital Adrenal Hyperplasia

    For Immediate Release: December 13, 2024 Today, the U.S. Food and Drug Administration approved Crenessity (crinecerfont) to be used together with glucocorticoids (steroids) to control androgen (a testosterone-like hormone) levels in adults and pediatric patients 4 years of age and older with classic congenital adrenal hyperplasia (CAH).“Today’s approval provides an important advance for patients with classic con

    12/13/24 5:54:17 PM ET
    $NBIX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIMC
    $ARDX
    $ASAN
    $BILI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bilibili Inc. to Report Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on Thursday, March 5, 2026

    SHANGHAI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bilibili Inc. ("Bilibili" or the "Company") (NASDAQ:BILI), an iconic brand and a leading video community for young generations in China, today announced that it will report its fourth quarter and fiscal year 2025 unaudited financial results on Thursday, March 5, 2026, before the open of U.S. markets. The Company's management will host an earnings conference call at 7:00 AM U.S. Eastern Time on March 5, 2026 (8:00 PM Beijing/Hong Kong Time on March 5, 2026). Details for the conference call are as follows: Event Title:Bilibili Inc. Fourth Quarter and Fiscal Year 2025 Earnings Conference CallRegistration Link:https://register-conf.media-server.com/

    2/12/26 5:00:00 AM ET
    $BILI
    EDP Services
    Technology

    StepStone Group partners with Utmost

    LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- StepStone Group (NASDAQ:STEP), a leading global private markets investment firm, announced today it is partnering with Utmost, a leading global provider of insurance-based wealth solutions. This provides Utmost's UK-based clients with access to StepStone's entire suite of evergreen global private markets strategies across Private Equity, Venture Capital & Growth, Private Credit, and Private Infrastructure. StepStone leverages a global perspective on private markets and relationships with a range of experienced investment managers across different investment strategies. Through this partnership, UK investors will be able to diversify their portfoli

    2/12/26 4:00:00 AM ET
    $STEP
    Investment Managers
    Finance

    Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026

    Total Fourth-Quarter and Full-Year 2025 Net Product Sales of $798.3 Million and $2.83 Billion, Representing Year-Over-Year Growth of 29% and 22%, Respectively INGREZZA® (valbenazine) Full Year 2026 Net Product Sales Guidance of $2.7 - $2.8 Billion SAN DIEGO, Feb. 11, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the fourth quarter ended December 31, 2025. "Our 2025 performance reflects the strength and durability of our commercial business and meaningful progress we are making transforming Neurocrine into a broader, m

    2/11/26 4:01:00 PM ET
    $NBIX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AIMC
    $ARDX
    $ASAN
    $BILI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Samsara with a new price target

    Goldman initiated coverage of Samsara with a rating of Buy and set a new price target of $36.00

    2/11/26 7:52:47 AM ET
    $IOT
    EDP Services
    Technology

    TD Cowen reiterated coverage on Marathon Petroleum with a new price target

    TD Cowen reiterated coverage of Marathon Petroleum with a rating of Buy and set a new price target of $198.00 from $183.00 previously

    2/4/26 7:58:31 AM ET
    $MPC
    Integrated oil Companies
    Energy

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $AIMC
    $ARDX
    $ASAN
    $BILI
    Leadership Updates

    Live Leadership Updates

    View All

    Kroger Appoints Greg Foran as Chief Executive Officer

    Accomplished Food Retail Leader Brings Strong Experience as Company Advances Its Growth Strategy Ron Sargent Continues as Chairman of Kroger's Board of Directors  CINCINNATI, Feb. 9, 2026 /PRNewswire/ -- The Kroger Co. (NYSE:KR) today announced its Board of Directors appointed Greg Foran as Chief Executive Officer, effective immediately. Foran will also join Kroger's Board of Directors and succeeds Ron Sargent, who served as interim CEO since March 2025. This announcement follows an extensive search process conducted by the Board to identify an innovative retail leader with a strong track record of execution at scale.

    2/9/26 7:30:00 AM ET
    $KR
    Food Chains
    Consumer Staples

    Old Spice's Most Sophisticated Cologne-Infused Scents Arrive Nationwide: Introducing the Spice Alchemist Collection

    Old Spice's New Premium Line is Crafted for Compliments with Scents Preferred Versus $300 Colognes Old Spice continues to redefine men's grooming with the Spice Alchemist collection, merging the artistry of a premium fine fragrance with cologne-infused scents and the brand's legendary, high-performance odor protection. This lineup embodies premium fragrances with scents that are preferred versus a $300 cologne in blind consumer testing, but at a fraction of the cost. Yes, you can have it all. Old Spice, the Greatest Smell in the NFL, will give fans a "sneak sniff" of Spice Alchemist at the "Unrivaled Freshness Experience" at Super Bowl LX in San Francisco, and the new lineup will continue

    2/4/26 8:06:00 AM ET
    $PG
    Package Goods/Cosmetics
    Consumer Discretionary

    StepStone Real Estate Adds Veteran Investor Jennifer Jones as Partner; Announces Launch of S-Core to Expand its Core/Core+ Real Estate Investment Offerings

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- StepStone Real Estate (SRE) announced today that it has added Jennifer Jones to its team as a Partner to help launch S-Core, a platform that will increase SRE's Core/Core+ real estate activities. Jones will be based in San Francisco and will oversee a global investment mandate. Prior to joining StepStone, Ms. Jones spent nearly two decades at UBS where she led over $20 billion in transactions and most recently was the Senior Portfolio Manager for its Global Core Plus vehicle for US Investors and for various Core+ separate accounts. She also served as Head of Real Estate Partnerships and Investments for UBS' $100+ billion Real Estate and Private

    1/27/26 8:05:00 AM ET
    $STEP
    Investment Managers
    Finance

    $AIMC
    $ARDX
    $ASAN
    $BILI
    Financials

    Live finance-specific insights

    View All

    Bilibili Inc. to Report Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on Thursday, March 5, 2026

    SHANGHAI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bilibili Inc. ("Bilibili" or the "Company") (NASDAQ:BILI), an iconic brand and a leading video community for young generations in China, today announced that it will report its fourth quarter and fiscal year 2025 unaudited financial results on Thursday, March 5, 2026, before the open of U.S. markets. The Company's management will host an earnings conference call at 7:00 AM U.S. Eastern Time on March 5, 2026 (8:00 PM Beijing/Hong Kong Time on March 5, 2026). Details for the conference call are as follows: Event Title:Bilibili Inc. Fourth Quarter and Fiscal Year 2025 Earnings Conference CallRegistration Link:https://register-conf.media-server.com/

    2/12/26 5:00:00 AM ET
    $BILI
    EDP Services
    Technology

    Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026

    Total Fourth-Quarter and Full-Year 2025 Net Product Sales of $798.3 Million and $2.83 Billion, Representing Year-Over-Year Growth of 29% and 22%, Respectively INGREZZA® (valbenazine) Full Year 2026 Net Product Sales Guidance of $2.7 - $2.8 Billion SAN DIEGO, Feb. 11, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the fourth quarter ended December 31, 2025. "Our 2025 performance reflects the strength and durability of our commercial business and meaningful progress we are making transforming Neurocrine into a broader, m

    2/11/26 4:01:00 PM ET
    $NBIX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Douglas Emmett Releases Fourth Quarter 2025 Earnings Results

    Douglas Emmett, Inc. (NYSE:DEI), a real estate investment trust (REIT), has released its Fourth Quarter 2025 Earnings Results and Operating Information package by posting it to the investor relations section of its website at www.douglasemmett.com/investors. As previously announced, Jordan Kaplan, Chairman & CEO, Peter Seymour, CFO, Kevin Crummy, CIO, and Stuart McElhinney, Vice President Investor Relations will host a live conference call to discuss Douglas Emmett's financial results at 2:00 pm Eastern Time (11:00 am Pacific Time) on Wednesday, February 11, 2026. Interested parties can listen to the call via the following: INTERNET: Go to www.douglasemmett.com/investors at least fiftee

    2/10/26 4:53:00 PM ET
    $DEI
    Real Estate Investment Trusts
    Real Estate

    $AIMC
    $ARDX
    $ASAN
    $BILI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Samsara Inc.

    SC 13D/A - Samsara Inc. (0001642896) (Subject)

    12/11/24 9:27:25 PM ET
    $IOT
    EDP Services
    Technology

    SEC Form SC 13D filed by First Solar Inc.

    SC 13D - FIRST SOLAR, INC. (0001274494) (Subject)

    12/10/24 1:11:10 PM ET
    $FSLR
    Semiconductors
    Technology

    Amendment: SEC Form SC 13D/A filed by StepStone Group Inc.

    SC 13D/A - StepStone Group Inc. (0001796022) (Subject)

    12/5/24 7:16:56 PM ET
    $STEP
    Investment Managers
    Finance